Efficacy and Safety of a Drug-Free, Barrier-Forming Nasal Spray for Allergic Rhinitis: Randomized, Open-Label, Crossover Noninferiority Trial

INTRODUCTION: Symptoms of allergic rhinitis can be reduced by nonpharmacological nasal sprays that create a barrier between allergens and the nasal mucosa. A new nasal spray (AM-301) containing the clay mineral bentonite was tested for its ability to reduce symptoms of grass pollen. METHODS: This op...

Descripción completa

Detalles Bibliográficos
Autores principales: Nehrig, Julian, Grosse, Nicole, Hohenfeld, Ilja P., Hohlfeld, Jens M., Badorrek, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Experimental Allergy − Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064392/
https://www.ncbi.nlm.nih.gov/pubmed/36323243
http://dx.doi.org/10.1159/000526423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064392/
https://www.ncbi.nlm.nih.gov/pubmed/36323243
http://dx.doi.org/10.1159/000526423

Ejemplares similares